Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

INGAP in first clinical trial to test islet neogenesis in diabetes patients

Jan. 21, 2002

Zimmer and Isto collaborate on Neocartilage allograft tissue development and commercialization

Jan. 21, 2002

Preparation and use of new thiourea NPY Y1 antagonists for eating disorders

Jan. 18, 2002

Alliance looks to resume phase III program for Oxygent

Jan. 18, 2002

Risedronate receives approval in Japan

Jan. 18, 2002

Squalamine enters clinical trials for fibrodysplasia ossificans progressiva

Jan. 18, 2002

Antagonists of NPY Y5 receptors reportedly useful for eating disorders, diabetes

Jan. 17, 2002

Positive results from phase II trial of SomatoKine in type 2 diabetes

Jan. 17, 2002

InFUSE Bone Graft recommended for approval for spinal fusion by FDA panel

Jan. 17, 2002

Diphenylmethane derivatives active as thyroid hormone receptor agonists

Jan. 16, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 23, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
Nankai University and Accendatech present new majusculamide D derivatives
BioWorld Science
Scientists from Nankai University Tianjin and Accendatech Technology Co. Ltd. have identified a majusculamide D derivative found to be useful for the treatment of...